NCT01653314View on ClinicalTrials.gov

Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Healthy
Interventions
DRUG

Megavec

DRUG

Glivec

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY